药学学报, 2018, 53(4): 567-573
引用本文:
翟园园, 刘其南, 徐佳, 姚卫峰, 包贝华, 曹雨诞, 张丽, 丁安伟. 基于网络药理学的二至丸保肝作用机制研究[J]. 药学学报, 2018, 53(4): 567-573.
ZHAI Yuan-yuan, LIU Qi-nan, XU Jia, YAO Wei-feng, BAO Bei-hua, CAO Yu-dan, ZHANG Li, DING An-wei. Network pharmacology-based study on mechanism of liver protection of Erzhi Pill[J]. Acta Pharmaceutica Sinica, 2018, 53(4): 567-573.

基于网络药理学的二至丸保肝作用机制研究
翟园园, 刘其南, 徐佳, 姚卫峰, 包贝华, 曹雨诞, 张丽, 丁安伟
南京中医药大学, 江苏省方剂高技术研究重点实验室/江苏省中药资源产业化过程协同创新中心, 江苏 南京 210023
摘要:
构建二至丸保肝的"成分-核心靶点-通路"分子调控网络,探索其"多成分-多靶点-多通路"的作用机制。采用ADME/T计算方法筛选二至丸保肝活性成分,通过网络药理学研究方法,基于反向药效团匹配的靶标识别服务平台分析预测潜在作用靶点,通过生物学信息注释数据库(DAVID)对靶点基因功能及代谢通路进行分析,采用Cytoscape软件构建二至丸保肝"成分-核心靶点-通路"网络模型。结果显示,二至丸中39个主要的保肝活性成分可能通过调控HRAS、DCK、HSD17B1和UCK2等321个靶点,干预胰岛素信号通路、FoxO信号通路、代谢通路和糖酵解过程等51条通路发挥保护肝脏作用,体现了中药多成分、多靶点和多途径的作用特点,为该复方作用机制的阐述提供了新的思路和线索。
关键词:    网络药理学      二至丸      女贞子      墨旱莲      保护肝脏      作用机制     
Network pharmacology-based study on mechanism of liver protection of Erzhi Pill
ZHAI Yuan-yuan, LIU Qi-nan, XU Jia, YAO Wei-feng, BAO Bei-hua, CAO Yu-dan, ZHANG Li, DING An-wei
Jiangsu Key Laboratory for High Technology Research of TCM Formulae and Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract:
This study was designed to construct a "drug-core target-pathway" network of Erzhi Pill for hepatic injury treatment in an effort to explore the "multi-components, multi-targets, multi-pathways" mechanism. ADME/T calculation method was used to screen the active components of Erzhi Pill, and then predict the potential targets according to the reverse pharmacophore matching method. Biological information annotation databases (DAVID) was used to analyze the molecular function and biological process of the action targets. The Cytoscape software was used to construct the "ingredient-core target-pathway" network of Erzhi Pill for hepatic injury treatment. It was found that 39 major active ingredients of Erzhi Pill regulated 321 targets (HRAS, DCK, HSD17B1, UCK2, et al) and affected 51 pathways, such as insulin signaling pathway, FoxO signaling pathway, metabolic pathways and glycolysis/gluconeogenesis. The method revealed the action features of traditional Chinese medicine as multi-ingredients, multi-targets, multi-pathways, providing new clues for further basic study on the hepatic injury pharmacological mechanism of Erzhi Pill.
Key words:    network pharmacology    Erzhi Pill    Nvzhenzi    Mohanlian    protection of liver    mechanism   
收稿日期: 2017-09-27
DOI: 10.16438/j.0513-4870.2017-0966
基金项目: 国家自然科学基金面上项目资助(81573554);江苏高校"青蓝工程"资助;江苏省"六大人才高峰"高层次人才项目资助(2016-YY026).
通讯作者: 姚卫峰,Tel:86-25-85811053,E-mail:yaowf@njucm.edu.cn
Email: yaowf@njucm.edu.cn
相关功能
PDF(356KB) Free
打印本文
0
作者相关文章
翟园园  在本刊中的所有文章
刘其南  在本刊中的所有文章
徐佳  在本刊中的所有文章
姚卫峰  在本刊中的所有文章
包贝华  在本刊中的所有文章
曹雨诞  在本刊中的所有文章
张丽  在本刊中的所有文章
丁安伟  在本刊中的所有文章

参考文献:
[1] Wang JD, Li P, Li YM. Research progress of therapeutic drugs for liver injury[J]. Chin J Hosp Pharm (中国医院药学杂志), 2013, 33:1528-1530.
[2] Goodman ZD. Phenotypes and pathology of drug-induced liver disease[J]. Clin Liver Dis, 2017, 21:89.
[3] Gao B, Xu MJ, Bertola A, et al. Animal models of alcoholic liver disease:pathogenesis and clinical relevance[J]. Gene Expr, 2017, 17:173-186.
[4] Lv XM, Ma LJ. Research progress in treatment of liver injury with Chinese Medicine[J]. Chin J New Drugs (中国新药杂志), 2016, 25:170-174.
[5] Hu DM, Chen XL, Lu Y, et al. Research progress on hepatoprotective effects of Erzhiwan and its components[J]. J Pharm Prac (药学实践杂志), 2016, 34:289-291, 296.
[6] Yao WF, Jiang YJ, Cai XJ, et al. Metabolomics study of Erzhi Pills on acute hepatic injury induced by CCl4 in rats[J]. Chin Pharm J (中国药学杂志), 2013, 48:808-812.
[7] Li H, Liu QN, Gao Y, et al. Urinal metabolomics study on intervention of Erzhi Pills on acute hepatic injury induced by alcohol in rats[J]. Chin Hosp Pharm J (中国医院药学杂志), 2016, 36:1665-1670.
[8] Liu ZH, Sun XB. Network pharmacology:new opportunity for the modernization of traditional Chinese medicine[J]. Acta Pharm Sin (药学学报), 2012, 47:696-703.
[9] Ru JL. Construction and Utilization of Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (中药系统药理学数据库和分析平台的构建和应用)[D]. Xianyang:North West Agriculture and Forestry University, 2015.
[10] Wang YH, Yang L. Systems pharmacology-based research framework of traditional Chinese medicine[J]. World Chin Med (世界中医药), 2013, 8:801-808.
[11] Lu Y, Hu DM, Wen AD, et al. The protective effect of privet total glycosides on acute liver injury mice[J]. Chin Pharm Bull (中国药理学通报), 2016, 32:588-589.
[12] Hu DM, Lu Y, Fang MF, et al. Protective effects of specnuezhenide against carbon tetrachloride-induced acute hepatic damage in mice[J]. Chin Pharm Bull (中国药理学通报), 2016, 32:1260-1263.
[13] Wang Y, He JJ. Protective effects of oleuropein on LPS-induced acute lung injury in mice[J]. Chin J Veter Med (中国兽医杂志), 2016, 52:8-11, 66.
[14] Pan S, Liu L, Pan H, et al. Protective effects of hydroxy-tyrosol on liver ischemia/reperfusion injury in mice[J]. Mol Nutr Food Res, 2013, 57:1218-1227.
[15] He MF, Hua FZ, Zhang J, et al. Influence of oleanolic acid pretreatment to the IKK/I-κB/NF-κB signaling pathway dur-ing rat's HIRI[J]. J Nanjing Med Univ (南京医科大学学报), 2011, 31:697-701.
[16] Zhang J, Wu SY, Wang L, et al. Effect of ursolic acid on the expression of PTP-1B、IRS-2 mRNA in liver tissues of rats with insulin resistance[J]. J Jiangsu Univ Tradit Chin Med (江苏中医药), 2010, 42:69-71.
[17] Ma A, Wang Y, Zhang Q. Tormentic acid reduces inflammation in BV-2 microglia by activating the liver X receptor alpha[J]. Neuroscience, 2015, 287:9-14.
[18] Yan SL, Yang HT, Lee HL, et al. Protective effects of maslinic acid against alcohol-induced acute liver injury in mice[J]. Food Chem Toxicol, 2014, 74:149-155.
[19] Cheng SD, Zhou HH, Zhao ZX, et al. Jiangzhi and hepato-protection effect of salidroside on nonacoholic fatty liver disease[J]. Chin J Tradit Chin Med Pharm (中华中医药杂志), 2013, 28:2701-2703.
[20] Lei J, Wen T. Effect of echinacoside on the protection of acute liver injury induced by concanavalin A in mice and its effect on extracellular histones[J]. Med J Chin People's Liber Arm (解放军医学杂志), 2016, 41:97-102.
[21] Yang SS, Shen AM, Ding LX, et al. Preparation of verbascoside solid lipid nanoparticles and its protective effects on acute liver injury in mice[J]. Chin J Hosp Pharm (中国医院药学杂志), 2014, 34:4-8.
[22] Dang YY, Ye XY, Shen J. Experimental study on the damage of glucose fluctuation on cultured human L02 hepatocytes[J]. J East China Norm Univ (华东师范大学学报), 2010, 2010:142-148.
[23] Wang LP, Wang C, Zhao YH, et al. Early intervention of extract of Nuzhenzi on liver injury in diabetic rats[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2017, 35:236-238, 288.
[24] Yang J. Protective Effect of Apigenin on Acetaminophen-induced Acute Liver Injury and Its Mechanisms (芹菜素对扑热息痛致急性肝损伤的保护作用及其机制研究)[D]. Suzhou:Suzhou University, 2013.
[25] Domitrovi R, Jakovac H, Tomac J, et al. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin[J]. Toxicol Appl Pharmacol, 2009, 241:311-321.
[26] Zhang Y. Protcective Effect of Nano-granulated Quercetin Liposome on Hepatic Injury in Rats (纳米脂质体槲皮素对肝损伤大鼠保肝作用的研究)[D]. Changsha:Central South University, 2012.
[27] Luo LN, Yang P, Huang W. The effect and mechanism of anthocyanin on hepatic ischemia reperfusion injury in rats[J]. J Xian Jiaotong Univ (西安交通大学学报), 2016, 37:594-598.
[28] Zhou L, Xie YY, Li Y, et al. Protcective effect of luteolin-7-O-β-D-glucopyranoside on hypoxic-ischemic injury of myocardial cells in neonatal rats[J]. Tradit Chin Drug Res Clin Pharm (中药新药与临床药理), 2008, 19:259-261.
[29] Yao F, Zhou QY, Xiong Y, et al. Protective effects of β-sitosterol on acute lung injury induced by lipopolysaccharide in mice[J]. Chin Agr Sci Bull (中国农学通报), 2015, 31:55-61.
[30] Tong FY, Luo C, Luo D, et al. Protective effects of kaempferol on CCl4-induced acute liver injury in mice[J]. J Xian Jiaotong Univ (西安交通大学学报), 2014, 35:816-819.
[31] Zhao X, Gou XJ, Chen L, et al. Metabonomic study of the preventive effects of taxifolin on CCl4-induced acute liver injury in rats[J]. J Shanghai Univ Tradit Chin Med (上海中医药杂志), 2017, 51:82-86.
[32] Zhu GF, Guo HJ, Huang Y, et al. Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity[J]. Exp Ther Med, 2015, 10:2259-2266.
[33] You B, Jiang YY, Chen S, et al. The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IκBα expression[J]. Circ Res, 2009, 104:742-749.
[34] Gruber F, Hufnagl P, Hofer-Warbinek R, et al. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1(PAI-1) promoter regulates TNF-induced PAI-1 expression[J]. Blood, 2003, 101:3042-3048.
[35] Hashem FA, Aboutabl EA, El-Souda SS, et al. Composition of lipoidal matter and evaluation of hepato-protective, cytotoxic, and antioxidant activities of Khaya grandifoliola C. DC. growing in Egypt[J]. Egypt Pharm J, 2014, 13:13-20.
[36] Batta AK, Xu G, Honda A, et al. Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat[J]. Metabolism, 2006, 55:292-299.
[37] Lee MK, Ha NR, Yang H, et al. Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells[J]. Phytomedicine, 2008, 15:775-780.
[38] Liu QM, Zhao HY, Zhong XK, et al. Eclipta prostrata L. phytochemicals:isolation, structure elucidation, and their antitumor activity[J]. Food Chem Toxicol, 2012, 50:4016-4022.
[39] Kim SJ, Cho HI, Kim SJ, et al. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure[J]. Euro J Pharmacol, 2014, 738:66-73.
[40] Jung JY, Lee CW, Park SM, et al. Activation of AMPK by Buddleja officinalis Maxim. flower extract contributes to protecting hepatocytes from oxidative stress[J]. Evid Based Complement Alternat Med, 2017, 2017:9253462.
[41] Qi PS, Pei SX, Ren JS. Protective effects of kaempferol on CCl4-induced acute liver injury in mice[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2006, 24:1539-1540.
[42] Chen C, Han XQ, Liu CH, et al. Effects of starfish saponins on insulin signaling pathway in muscle of NAFLD rats[J]. Chin Pharm Bull (中国药理学通报), 2017, 33:512-516.
[43] Cordeiro A, Souza LL, Einickerlamas M, et al. Non-classic thyroid hormone signalling involved in hepatic lipid metabolism[J]. J Endocrinol, 2013, 216:47-57.
[44] Wang GL. Effects of Sirt1-FOXO1 Signaling Pathway on Lipid Metabolism of Hepatocytes and Related Regulatory Mechanisms (Sirt1-FOXO1信号通路对肝细胞脂代谢的影响及相关调节机制)[D]. Shantou:Shantou University, 2009.
[45] Jia HM. Proceeding of 2011 Chinese Pharmaceutical Congress and the 11th Chinese Pharmacists Week (2011年中国药学大会暨第11届中国药师周论文集)[C]. Yantai:Chinese Pharmaceutical Association, Yantai Municipal People's Government, 2011:3.
[46] Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis:signalling pathways, biological responses and therapeutic inhibition[J]. Trends Pharmacol Sci, 2001, 22:201-207.
[47] Che Q. Glycolysis Inhibitor 2-Deoxyglucose Alleviated Acute Liver Injury Induced by Lipopolysaccharide/D-Galactosamine in Mice (糖酵解抑制剂2-脱氧葡萄糖减轻LPS/D-Gal诱导的急性肝损伤)[D]. Chongqing:Chongqing Medical University, 2015.
[48] Zhang MF, Shen YQ. Research advances on hepatoprotective effects of Ligustri Lucidi Fructus and its active constituents[J]. Drug Ev Res (药物评价研究), 2014, 37:280-284.
[49] Liu TT, Wang M. Research progress of chemical composition and pharmacological effects of Fructus Figustri Lucidi[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2014, 20:228-234.
[50] Fang Y, Li XC, Zhang ZF. Research advances on chemical constituents and pharmacological effects of Herba Ecliptae[J]. J Str Pharm (海峡药学), 2015, 27:1-3.
[51] Zhou HY, Tang W, Jiang J, et al. Effects of β-sitosterol and stigmasterol on non-alcoholicfatty liver disease in vitro[J]. Acta Nutr Sin (营养学报), 2016, 38:456-461.
[52] Huang JC, Qing LJ, Xuan YY, et al. Study on antioxidant activity of stigmaserol from Yulangsan in vitro[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2014, 20:154-156.
[53] Xi YL, Wu QK, Feng W, et al. The protective effects of oleanolic acid against carbon tetrachloride-induced acute liver injury in rats[J]. J Jilin Univ Tradit Chin Med (吉林医药学院学报), 2015, 36:1-3.
相关文献:
1.王珂欣, 高丽, 周玉枝, 张建琴, 秦雪梅, 杜冠华.基于网络药理学的苦参碱抗肝癌作用及机制研究[J]. 药学学报, 2017,52(6): 888-896
2.赵蕾, 武嫣斐, 高耀, 向欢, 秦雪梅, 田俊生.基于网络药理学的百合地黄汤干预心理亚健康作用机制研究[J]. 药学学报, 2017,52(1): 99-105
3.孙莉敏, 刘丽芳, 朱华旭, 朱宝杰, 张启春.基于网络药理学的黄连解毒汤治疗阿尔兹海默症的作用机制研究[J]. 药学学报, 2017,52(8): 1268-1275
4.陶瑾, 姜民, 陈露莹, 侯媛媛, 张德芹, 邱峰, 白钢.基于中药性味理论和网络药理学方法的治疗消渴方药作用机制研究[J]. 药学学报, 2017,52(2): 236-244
5.牟海栋, 屠鹏飞, 姜勇.基于网络药理学的肉桂温经通脉的作用机制研究[J]. 药学学报, 2016,51(11): 1724-1733
6.韩彦琪, 许浚, 张喜民, 张铁军, 任一杰, 刘昌孝.基于网络药理学的元胡止痛滴丸治疗原发性痛经的作用机制研究[J]. 药学学报, 2016,51(3): 380-387
7.白雨, 范雪梅, 孙瀚, 王义明, 梁琼麟, 罗国安.基于网络药理学的罗格列酮复方作用机制探讨[J]. 药学学报, 2015,50(3): 284-290